PCA
EDIT icon

Pallas Capital Advisors’s Editas Medicine EDIT Stock Holding History

Pallas Capital Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.9K Sell
11,711
-4,865
-29% -$14.2K ﹤0.01% 994
2026
Q1 		$40.9K Buy
+16,576
New +$35.1K ﹤0.01% 841
2025
Q2 		– Sell
-16,275
Closed -$18.9K – 888
2025
Q1 		$18.9K Buy
+16,275
New +$23.9K ﹤0.01% 743

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Pallas Capital Advisors's EDIT Position: Q2 2026 in Review

Pallas Capital Advisors reduced its Editas Medicine (EDIT) stake by 29% in Q2 2026, selling an estimated $14.2K and leaving 11,711 shares worth $37.9K. The position accounts for ﹤0.01% of the portfolio, ranked #994.

Pallas Capital Advisors first reported a position in EDIT in Q1 2025 and has held it in 3 quarters since. The position peaked at $40.9K in Q1 2026. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Pallas Capital Advisors held 11,711 shares of Editas Medicine worth $37.9K as of Q2 2026.
  • Pallas Capital Advisors sold 4,865 Editas Medicine shares in Q2 2026, an estimated $14.2K.
  • Editas Medicine made up ﹤0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #994 holding.
  • Pallas Capital Advisors first reported a position in Editas Medicine in Q1 2025 and has held it in 3 quarters since.
  • Pallas Capital Advisors's Editas Medicine position peaked at $40.9K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.